A vaccine for Shigella developed by scientists at the University of Kansas (KU) and Oklahoma State University (OSU) will go through Phase I clinical trials at a medical center in the Baltimore, MD, area later this year. http://www.dreamstime.com/stock-photography-doctor-give-injection-to-boy-s-arm-image33311792The trials are a milestone for research now centered at the new Kansas Vaccine Institute (KVI) at the University of Kansas School of Pharmacy. The KVI, established last summer with financing which included state funding, brought former KU students William and Wendy Picking back to the Lawrence, KS, campus to work on vaccines for bacterial pathogens responsible for digestive diseases. Dr. William D.
Continue Reading Kansas Institute Moves Shigella Vaccine Out for Clinical Trials